Forecast & Rating2 analysts currently cover Kairos Pharma, of which 2 give a positive rating. The average price target is $49.00, about 2652.9% upside from the current price of $1.78. Coverage is limited, so the data is for reference only. Data as of Sep 1, 2026; this does not constitute investment advice.
Jul 27, 2026Price forecast
$49.002652.95%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 3, 2026
Forecast met0.0%
Stock price$2.17
Avg. target$49.0
High target$84
Low target$14
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.